Non‐invasive tests for liver fibrosis in NAFLD: Creating pathways between primary healthcare and liver clinics
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Non‐invasive tests for liver fibrosis in NAFLD: Creating pathways between primary healthcare and liver clinics
Authors
Keywords
-
Journal
LIVER INTERNATIONAL
Volume 40, Issue S1, Pages 77-81
Publisher
Wiley
Online
2020-02-20
DOI
10.1111/liv.14347
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Non-Invasive Assessment of Liver Disease in Patients with NAFLD
- (2019) Laurent Castera et al. GASTROENTEROLOGY
- Unified interpretation of liver stiffness measurement by M and XL probes in non-alcoholic fatty liver disease
- (2019) Vincent Wai-Sun Wong et al. GUT
- Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
- (2019) Peter J. Eddowes et al. GASTROENTEROLOGY
- Optimizing Use of Nonalcoholic Fatty Liver Disease Fibrosis Score, Fibrosis-4 Score, and Liver Stiffness Measurement to Identify Patients with Advanced Fibrosis
- (2019) Wah-Kheong Chan et al. Clinical Gastroenterology and Hepatology
- Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease
- (2019) Ankur Srivastava et al. JOURNAL OF HEPATOLOGY
- New sequential combinations of noninvasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD
- (2019) Jérôme Boursier et al. JOURNAL OF HEPATOLOGY
- Noninvasive tests accurately identify advanced fibrosis due to NASH : Baseline data from the STELLAR trials
- (2019) Quentin M. Anstee et al. HEPATOLOGY
- Direct comparison of the specialised blood fibrosis tests FibroMeterV2G and Enhanced Liver Fibrosis score in patients with non-alcoholic fatty liver disease from tertiary care centres
- (2019) Maeva Guillaume et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Performance of Plasma Biomarkers and Diagnostic Panels for Nonalcoholic Steatohepatitis and Advanced Fibrosis in Patients With Type 2 Diabetes
- (2019) Fernando Bril et al. DIABETES CARE
- Vibration-controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease
- (2018) Mohammad S. Siddiqui et al. Clinical Gastroenterology and Hepatology
- Liver Ultrasound Elastography: An Update to the World Federation for Ultrasound in Medicine and Biology Guidelines and Recommendations
- (2018) Giovanna Ferraioli et al. ULTRASOUND IN MEDICINE AND BIOLOGY
- Diagnostic accuracy of point shear wave elastography and transient elastography for staging hepatic fibrosis in patients with non-alcoholic fatty liver disease: a meta-analysis
- (2018) Weixi Jiang et al. BMJ Open
- Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis
- (2017) Guangqin Xiao et al. HEPATOLOGY
- Performance characteristics of vibration-controlled transient elastography for evaluation of nonalcoholic fatty liver disease
- (2017) Raj Vuppalanchi et al. HEPATOLOGY
- Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis
- (2017) Parambir S. Dulai et al. HEPATOLOGY
- Assessment of biopsy-proven liver fibrosis by two-dimensional shear wave elastography: An individual patient data-based meta-analysis
- (2017) Eva Herrmann et al. HEPATOLOGY
- Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD
- (2017) Hannes Hagström et al. JOURNAL OF HEPATOLOGY
- Concomitant screening for liver fibrosis and steatosis in French type 2 diabetic patients using Fibroscan
- (2017) Dominique Roulot et al. LIVER INTERNATIONAL
- EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Short Version)
- (2017) Christoph Dietrich et al. ULTRASCHALL IN DER MEDIZIN
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease
- (2016) Jérôme Boursier et al. JOURNAL OF HEPATOLOGY
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) JOURNAL OF HEPATOLOGY
- Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study
- (2015) Raymond Kwok et al. GUT
- EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis
- (2015) JOURNAL OF HEPATOLOGY
- Nonalcoholic Fatty Liver Disease is Underrecognized in the Primary Care Setting
- (2014) Pierre Blais et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Applicability and precautions of use of liver injury biomarker FibroTest. A reappraisal at 7 years of age
- (2011) Thierry Poynard et al. BMC GASTROENTEROLOGY
- Pitfalls of liver stiffness measurement: A 5-year prospective study of 13,369 examinations
- (2009) Laurent Castéra et al. HEPATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started